Hennion & Walsh Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Buy |
48,491
+2,342
| +5% | +$172K | 0.14% | 177 |
|
|
2025
Q1 | $5.27M | Sell |
46,149
-1,973
| -4% | -$225K | 0.23% | 89 |
|
|
2024
Q4 | $2.42M | Sell |
48,122
-21,205
| -31% | -$1.07M | 0.11% | 241 |
|
|
2024
Q3 | $3.21M | Buy |
69,327
+9,838
| +17% | +$455K | 0.15% | 180 |
|
|
2024
Q2 | $1.93M | Buy |
59,489
+4,620
| +8% | +$150K | 0.1% | 255 |
|
|
2024
Q1 | $1.38M | Buy |
54,869
+15,335
| +39% | +$386K | 0.07% | 339 |
|
|
2023
Q4 | $1.28M | Sell |
39,534
-573
| -1% | -$18.6K | 0.07% | 347 |
|
|
2023
Q3 | $1.09M | Buy |
40,107
+6,756
| +20% | +$184K | 0.07% | 340 |
|
|
2023
Q2 | $742K | Buy |
33,351
+3,406
| +11% | +$75.8K | 0.04% | 428 |
|
|
2023
Q1 | $649K | Buy |
29,945
+9,851
| +49% | +$214K | 0.04% | 448 |
|
|
2022
Q4 | $408K | Buy |
+20,094
| New | +$408K | 0.03% | 541 |
|
|
2021
Q2 | – | Sell |
-10,771
| Closed | -$256K | – | 731 |
|
|
2021
Q1 | $256K | Buy |
+10,771
| New | +$256K | 0.02% | 632 |
|